A 35-year-old patient with relapsing-remitting multiple sclerosis has frequent relapses impacting daily life. According to NICE guidelines which of th...

Question

A 35-year-old patient with relapsing-remitting multiple sclerosis has frequent relapses impacting daily life. According to NICE guidelines which of the following disease-modifying therapies is recommended first-line for active RRMS?

Accepted Answer

Interferon beta or glatiramer acetate

Answer

Natalizumab

Answer

High-dose steroids continuously

Answer

Mitoxantrone

Answer

Cyclophosphamide

ukmla MCQ (SBA): Multiple Sclerosis

A 35-year-old patient with relapsing-remitting multiple sclerosis has frequent relapses impacting daily life. According to NICE guidelines which of the following disease-modifying therapies is recommended first-line for active RRMS?